Down about 300,000 shares
Avg Daily Share Volume
Days To Cover
6/30/2015 4,430,273 503,843 8.792963
6/15/2015 4,737,887 373,575 12.682559
......wonder if some of the Regeneron and Vertex investors could be talked into coming over to Insmed??
---UBS downgraded Regeneron today
---Wainwright the other day kept a neutral rating and a headline mentioned a possible 35% decrease
Come on in, REGN and VRTX investors........the water is fine here.
NO KIDDING with regards to the shot. I would want them to put me out first before they give me the shot in the eye.
Yes, in fact, here is a press release from 2007. Also, don't forget igfbp3 with regards to cancer.
June 26, 2007
Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
Key Protein in Company's Drug IPLEX(TM) is Seen Playing Lead Role in Development of Healthy Eyesight
RICHMOND, Va., Jun 26, 2007 (BUSINESS WIRE) -- Insmed Incorporated (Nasdaq:INSM), a biopharmaceutical company focused on the development and approval of drugs for the treatment of metabolic diseases with unmet medical needs, today noted the publication of promising results of research from three universities regarding the potential role of insulin-like growth factor binding protein-3 (IGFBP-3) in the prevention of blindness among premature infants.
IGFBP-3 is a key component of Insmed's lead drug candidate, IPLEX(TM), which has been approved by the U.S. Food and Drug Administration for the treatment of a severe growth disorder and is currently being studied as a treatment for myotonic muscular dystrophy, HIV-associated adipose redistribution syndrome and retinopathy of prematurity (ROP). IPLEX(TM) is the combination of IGFBP-3 with recombinant human insulin-like growth factor 1 (IGF-I).
The new study results, published in the June 19 issue of the Proceedings of the National Academy of Sciences, focus on the action of IGFBP-3 in promoting normal tissue growth and preventing ROP. Researchers at the University of Florida reported that mice treated with IGFBP-3 showed closer-to-normal growth of retinal vasculature than mice without IGFBP-3 in similar high-oxygen conditions. Researchers at Harvard Medical School and the University of Goteborg in Sweden reported similar results.
In addition, Harvard Medical School researchers, in collaboration with researchers at the University of Goteborg, reported results of a clinical study showing IGFBP-3 levels in infants with ROP were lower than those of healthy babies. The researchers said these results suggest that IGFBP-3,
"If things go right and Insmed gets sold- you will see EXACTLY what Iplex is worth ."
Terry, this comment of yours is EXACTLY why I want Insmed to go it alone or with a partner.....OR.....entertain offers after 2018.
.....no news here, I just like to see our resident spammers get into a state of apoplexy over the mention of this word. I think the discussion of iPlex a couple weeks ago sent them into the bunker to come up with their current posting strategy.
......may we keep in mind what the cost of our Independence, from the beginning until now, has cost our citizens.
Regardless what has happened in the past, I pray that God will still Bless America. It's hard for me to imagine that, but He is in control.
One of my favorite Chris Tomlin songs is "At the Cross (Love Ran Red)"......and a subsequent lyric is "....and my sins washed white". For those wanting to listen, you can google it and find a youtube link.
I'm a longer term holder than 1-day............I would have been happier if we could have burst through resistance. However, I am happy with the last three months and YTD. I also have mixed feelings on the following......I would be real happy if the price went down to around $21.50 so I could buy some more shares.
My turn? Start talking? LOL.....8-).......you must be used to ordering people around and getting your way. You could use some good manners skills, however. I will humbly decline your offer for my speaking. That's a nice list of stocks you own....not sure why, but I imagined you also an aria person. I don't remember you asking for that information, though.
I must admit I have said that same thing about myself here often. In comparison to some here, I really know and understand squat here. However, this I am not ashamed to admit, based upon what dd I have done and understand, I am very happy and consider myself fortunate to be invested in Insmed.
8-).........I gather you are upset I gave you a "thumbs down"....OK, fair enough. However, with all of your questions there, did I miss your answer to my question?